Open pergolide treatment of tricyclic and heterocyclic antidepressant-resistant depression

Journal of Affective Disorders

Volumn 61, Issue 1-2, 2000, Pages 127-132

  Izumi, Takeshi ^a   Inoue, Takeshi ^a   Kitagawa, Nobuki ^a   Nishi, Nobuyuki ^a   Shimanaka, Shoji ^a   Takahashi, Yoshito ^a   Kusumi, Ichiro ^a   Odagaki, Yuji ^a   Denda, Kenzo ^a   Ohmori, Testuro ^a   Koyama, Tsukasa ^a  

^a HOKKAIDO UNIVERSITY   (Japan)

Author keywords

Dopamine; Pergolide; Refractory depression; Treatment resistant depression

Indexed keywords

HETEROCYCLIC COMPOUND; PERGOLIDE; TRICYCLIC ANTIDEPRESSANT AGENT;

ADULT; ARTICLE; CLINICAL ARTICLE; DEPRESSION; DOPAMINERGIC ACTIVITY; DRUG EFFICACY; DRUG RESPONSE; FEMALE; HUMAN; MALE; PRIORITY JOURNAL; TREATMENT OUTCOME;

ADULT; AGED; ANTIDEPRESSIVE AGENTS; DEPRESSIVE DISORDER, MAJOR; DOPAMINE AGONISTS; FEMALE; HUMANS; MALE; MIDDLE AGED; PERGOLIDE; TREATMENT FAILURE;

EID: 0034541260     PISSN: 01650327     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-0327(99)00199-8     Document Type: Article

References (12)

1. Pergolide: An antidepressant adjuvant for mood disorders?
2. Bromocriptine in depression
3. Dopamine and depression
4. Pergolide: A dopamine agonist at both D1 and D2 receptors
5. Bromocriptine treatment of tricyclic and heterocyclic antidepressant-resistant depression
6. The motor effects of bromocriptine: A review
7. Role of dopamine mechanisms in the affective disorders
8. Special feature: Rating scales and assessment instruments for use in pediatric psychopharmacology research
9. Psychiatric applications of bromocriptine therapy
10. A comparative, multicenter trial between bromocriptine and amitriptyline in the treatment of endogenous depression
11. Bromocriptine and imipramine in endogenous depression: A double-blind controlled trial in outpatients
12. Dopaminergic mechanisms in depression and mania